Pharmafile Logo

SCM Pharma

SCM Pharma is a contract development & manufacturing organisation (CDMO) that develops and makes novel, difficult and dangerous drugs on behalf of our clients. Our formulation development, cGMP manufacturing and aseptic processing services include the sterile filling of liquids, gels and powders (including flammable products) into a range of final dosage forms including ampoules, vials, cartridges, syringes and bottles. So if you’re a pharmaceutical, biotech, medical device or healthcare institution in need of formulation development, clinical manufacturing or contract filling involving a complex product or process – let’s talk.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Unit 6 Regents Drive, Low Prudhoe Industrial Estate, Prudhoe, Northumberland, NE42 6PX, United Kingdom
+44(0) 1661 833 693

 Latest Content from PMHub 

Beyond Knowledge Transfer: Generating Actionable Insights for Medical Affairs

Presented at Evidence Life Science’s Medical Affairs Digital Conference March 9, 2021. Presenters: Christina L. Hoffman, MS, Global Lead for Medscape Medical Affairs Gökhan Tanju, Executive Director, Business Intelligence for...

Actionable Insights for Medical Affairs Teams: Lessons from the Front Lines

Presented at Fierce Pharma’s Medical Affairs Launch Excellence Conference February 4, 2021. With Christina L. Hoffman, MS, Global Lead for Medscape Medical Affairs. Chris speaks to two primary remits: Knowledge...

Patient Centric Approaches for Rare and Ultra-Rare Diseases

Lawrence Bressler, Head of Value & Market Access, Global Rare Diseases at Chiesi, shares how Chiesi is revolutionizing the lives of people living with rare diseases on a global scale....

Bedrock expands growing strategy and scientific teams

Press Releases | October 13, 2022 | Resonant Group

Award-winning Bedrock Healthcare Communications adds three new starters at an exciting time of growth. Meet our new faces and find out what drew them to Bedrock.

Genesis Research Insights & Evidence webinar 20 Oct: Reserve your place!

Join Priti Jhingran of Genesis Research and Tijana Ignjatovic of Market Access Transformation (MAT) for their webinar 'Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to...

WRG Launches Attendee Experience Design (AXD) Unit

WRG, the events and experiential division of The Creative Engagement Group, launches Attendee Experience Design (AXD) Unit. Combining Behavioural Science, Data Insights, and Digital and Live UX in One Unit

#Wellbeing Week: Let’s tackle pressure

White Papers and Resources | October 13, 2022 | Fox&Cat

Hear from Paul Hutchings, founder of foxandcat.online, with tips and advice to help your comms team thrive under pressure

The promised land of gene therapy: Commercialization of novel gene-editing technology in beta-thalassemia

With transformative treatments that leverage CRISPR technology, there are many challenges to overcome throughout the journey of development through to patient access. We interviewed a researcher at a top 20...

Infographic: Therapy Watch Psoriasis

White Papers and Resources | October 10, 2022 | Inizio

Our PsO infographic offers an introduction to the real-world patient insights collected by our Therapy Watch PsO study.

Porterhouse Insights celebrates its 5th anniversary

Porterhouse Medical Group is celebrating the 5th anniversary of Porterhouse Insights, its global research, insights and evidence consultancy.